For every study we do, one thing remains the same – getting your therapies to market on time and on budget. After only two years in business, this approach has delivered some exciting results.
Explore recent studies and the people who made them possible.
A Generic Immunoassay for High-Quality PK Data
Critical PK and PK/PD Experiments for Early-Stage Drug Development